Please login to the form below

Ashfield U.S. hires two senior executives for new Medical Affairs business unit

Ashfield U.S. is pleased to announce the appointment of Amy Van Sant as President of their new Medical Affairs business unit and Lee Ann Chaiken as Senior Vice President of Ashfield’s Pharmacovigilance business.

The new Medical Affairs business unit will combine Ashfield’s existing Medical Information, Pharmacovigilance and Medical Science Liaison services. The unit is being established as part of Ashfield’s five-year growth plan to provide its clients leading services across the entire healthcare value chain by investing in people, technology and infrastructure. Amy’s role will be focused on raising awareness of Ashfield’s Medical Affairs capabilities and executing the flexible and scalable programs clients require. She will be located in the Fort Washington, PA corporate headquarters of Ashfield U.S.  

Commenting on the appointments and launch of the Medical Affairs business unit, Greg Flynn, President Ashfield U.S. said: “I am delighted to welcome Amy and Lee to Ashfield.  Investment in talent is key to our business, and we are delighted to have these leaders with deep subject matter expertise join us. Their appointments underscore our commitment to providing best-in-class medical affairs solutions and providing our biopharmaceutical clients with seamless, end-to-end commercialisation services. We believe having one business unit, under the capable direction of Amy Van Sant, will offer our clients a much stronger and effective solution to their medical affairs issues.“
Click here to read the whole article.

15th February 2018


Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield’s highlights from eyeforpharma Barcelona 2018
This week we were delighted to attend eyeforpharma Barcelona 2018 as global sponsors, where we ran a communications strategy workshop using our new Humanise framework and Nagore Fernandez, Head of Clinical Services for EUCAN, hosted part of the Commercial track.
Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.